Anti-obesity drugs, the benefits, and the future of weight management

As more data is released with anti-obesity drugs, such as the recent discovery with Novo Nordisk's Wegovy (NVO) trials, the hype around these medications increase. Questions arise around the long-term effects they have on patients and the future of weight management since the market potential for these is massive.
As part of Yahoo Finance's Healthcare week, Anjalee Khemlani sat down with Dr. Angela Fitch, President of the Obesity Medicine Association, to discuss these long-term effects of these drugs and analyzed the care necessary to treat obesity with and without these medications.
Dr. Fitch responds to questions about whether or not these medications will truly be successful since patients often struggle with staying on medications: "The recent data is a little bit misleading, because we haven't been able to keep patients on medication. We've had a lot of telemedicine companies and other companies that have come forward, taking advantage of this space, of getting patients access to medication. But it's more than getting a patient access to a drug, it's about getting a patient to a doctor who can take care of them, and that's a different story than someone just texting and getting a drug via text... The more we treat obesity as a chronic disease, we are going to see more and more patients being able to tolerate these medications and stay on treatment."
For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.

Connect with Yahoo Finance: